Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism
作者:
Markus Lutz,
Matthias Schwab,
Ernst-Ulrich Griese,
Claudia Marx,
Bruno Müller-Oerlinghausen,
Peter Schönhöfer,
Christoph Meisner,
Christoph Gleiter,
Michel Eichelbaum,
Klaus Mörike,
期刊:
Pharmacogenetics
(OVID Available online 2002)
卷期:
Volume 12,
issue 1
页码: 73-75
ISSN:0960-314X
年代: 2002
出版商: OVID
数据来源: OVID
摘要:
Risk factors for patients developing visual disturbances in association with proton pump inhibitors are unknown. As omeprazole is substantially metabolized by polymorphic CYP2C19, we retrospectively identified and genotyped patients who experienced this adverse reaction. Among 29 patients, we found two poor metabolizers (PMs) of CYP2C19. The PM genotype does not appear to be a risk factor for omeprazole-associated visual disorders.
点击下载:
PDF
(105KB)
返 回